Catheter ablation of atrial fibrillation in the young: a systematic
review and meta-analysis
Abstract
Aims The differences in the clinical outcomes of rhythm and
safety after catheter ablation in young and old atrial fibrillation(AF)
patients remain unclear. The purpose of this study was to compare the
clinical outcomes of catheter ablation for in young and old AF patients.
Methods and results The Medline and EMBASE databases were
searched for published articles up to Octomber 2022. Studies that met
our predefined inclusion criteria were included. The primary endpoints
were freedom from AF/atrial tachycardia (AT) recurrence, safety
ouctcomes including the stroke/transient ischaemic attack (TIA), cardiac
tamponade and pericardial effusion. After literature search and detailed
assessment, 6 studies (9982 patients) were identified. Our analyses
showed that the rate of freedom from AF/AT recurrence was higher in
young than old AF patients after ablation [odds ratio (OR): 0.58, 95%
confidence interval (CI) 0.36–0.92; P -0.02]. Compared to older
patients, there were similar rate of adverse outcomes including
pericardial effusion /tamponade (OR=0.61, 95%CI 0.29-1.27,P=0.18),
hematoma(OR=1.87, 95%CI 0.62,5.63, P=0.27) and stroke/ TIA
rate(OR=0.25, 95%CI 0.05,1.41, P=0.12) . Conclusions In
younger atrial fibrillation patients, there is a lower major
complication rate and a comparable efficacy rate, with a greater chance
of being AF free without antiarrhythmic drugs. These findings suggest
that it may be appropriate to consider ablative therapy as first-line
therapy in this age group.